Type 2 inflammation influences the severity of post-acute sequelae of SARS-CoV-2, highlighting the need for targeted interventions. Innovative therapies like ALIS, tezepelumab, and dupilumab show ...
Lauren (Hansen) Holznienkemper is a lead editor for the small business vertical at Forbes Advisor, specializing in HR, payroll and recruiting solutions for small businesses. Using research and writing ...
CAMBRIDGE, Ontario--(BUSINESS WIRE)--ATS Corporation (TSX: ATS) (NYSE: ATS) (“ATS” or the “Company”) today released its FY2024 Sustainability Report, for the period ending March 31, 2024. This report, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results